ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYB WisdomTree Chinese Yuan Strategy Fund

24.2674
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Name Symbol Market Type
WisdomTree Chinese Yuan Strategy Fund AMEX:CYB AMEX Exchange Traded Fund
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 24.2674 0 01:00:00

Cybex Announces Q3 Results

02/11/2006 1:49pm

Business Wire


WisdomTree Chinese Yuan ... (AMEX:CYB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more WisdomTree Chinese Yuan ... Charts.
Cybex International, Inc. (AMEX: CYB), a leading exercise equipment manufacturer, today reported results for the third quarter ended September 30, 2006. Net sales for the third quarter 2006 were $29,849,000, compared to $26,690,000 for the third quarter 2005, an increase of 12%. On a GAAP basis, the Company reported net income for the third quarter of 2006 of $817,000, or $.05 per diluted share, compared to a net loss of $3,535,000, or $(.23) per diluted share, for the corresponding period of 2005. Excluding a third quarter 2005 litigation-related charge, and after an adjustment to the tax provision as described below, the Company’s third quarter 2005 non-GAAP net income was $346,000, or $.02 per diluted share. For the nine months ended September 30, 2006, net sales were $88,712,000, compared to $78,646,000 for 2005, an increase of 13%. On a GAAP basis, the Company reported net income for the nine months ended September 30, 2006 of $17,592,000, or $1.05 per diluted share, compared to a net loss of $2,378,000, or $(.16) per diluted share, for the corresponding period of 2005. Excluding a second quarter 2006 reduction of the valuation reserve for deferred taxes and the third quarter 2005 litigation-related charge, and after adjustments to the Company’s tax provision for each period as described below, the Company’s non-GAAP net income for the nine months ended September 30, 2006 was $2,287,000, or $.14 per diluted share, compared to non-GAAP net income of $1,073,000, or $.07 per diluted share, for the corresponding 2005 period. Actual GAAP results for the nine months ended September 30, 2006, include a $14,421,000 reduction in the Company’s deferred tax valuation reserve, resulting in a net tax benefit of $13,735,000 for the nine months ended September 30, 2006. Actual GAAP results for the third quarter and nine months ended September 24, 2005 included an increase in the Company’s litigation reserve resulting in a pre-tax charge of $4,101,000. This increase in the litigation reserve reflected the jury verdict in a patent infringement case and the reversal on appeal of a summary judgment in favor of the Company in another patent infringement case. The Company’s appeal of the jury verdict is pending and it continues to vigorously defend the other patent infringement suit which has since returned to the trial level. The Company’s deferred tax valuation reserve was reduced effective July 1, 2006, and the GAAP results for the quarter and nine months ended September 30, 2006 include a third quarter 2006 tax provision reflecting an effective tax rate of approximately 41%. The 2006 non-GAAP results include a tax provision calculated as though the Company’s effective tax rate for the third quarter 2006 was applicable for all of the first nine months of 2006, while the 2005 non-GAAP results include a tax provision at approximately the same effective rate. The non-GAAP adjustments have been made to provide a basis for reviewing the Company’s operating performance on a consistent basis for all of the periods presented. John Aglialoro, Chairman and CEO, stated, “We are excited about our re-entry into the high-end consumer market with our recent introduction of our Consumer Arc Trainer. The Company is aggressively advancing our new product development pace and CYBEX is poised for an exciting new product line-up for 2007.” Cybex International, Inc. is a leading manufacturer of premium exercise equipment for commercial and consumer use. The CYBEX product line includes a full range of both strength training and cardio training machines sold worldwide under the CYBEX brand. Products and programs are designed and engineered to reflect the natural movement of the human body, assisting each unique user – from the professional athlete to the first-time exerciser – to improve daily human performance. For more information on CYBEX and its product line, please visit the Company’s website at www.cybexinternational.com. This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, economic conditions, the resolution of litigation involving the Company, and the ability of the Company to comply with the terms of its credit facilities. Further information on these and other factors which could affect the Company’s financial results can be found in the Company’s previously filed Report on Form 10-K, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated April 4, 2006. CYBEX INTERNATIONAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - ACTUAL (In thousands, except per share data) (unaudited)   Three Months Ended Nine Months Ended September 30, September 24, September 30, September 24, 2006  2005  2006  2005    Net sales $ 29,849  $ 26,690  $ 88,712  $ 78,646  Cost of sales   19,269    17,143    56,719    50,593  Gross profit 10,580  9,547  31,993  28,053  As a percentage of sales 35.4% 35.8% 36.1% 35.7% Selling, general and administrative expenses 9,052  8,276  26,973  24,325  Litigation charges --    4,101  --    4,101  Operating income (loss) 1,528  (2,830) 5,020  (373) Interest expense, net   150    679    1,163    1,894  Income (loss) before income taxes 1,378  (3,509) 3,857  (2,267) Income tax provision (benefit)   561    26    (13,735)   111  Net income (loss) $ 817  $ (3,535) $ 17,592  $ (2,378) Basic net income (loss) per share $ .05  $ (.23) $ 1.09  $ (.16) Diluted net income (loss) per share $ .05  $ (.23) $ 1.05  $ (.16) Shares used in computing basic net income (loss) per share   17,185    15,130    16,128    15,119  Shares used in computing diluted net income (loss) per share   17,807    15,130    16,794    15,119  CYBEX INTERNATIONAL, INC. RECONCILIATION OF GAAP TO NON-GAAP RESULTS (In thousands, except per share data) (unaudited)   Three Months Ended Nine Months Ended September 30, 2006 September 24, 2005 September 30, 2006 September 24, 2005   GAAP net income (loss) $ 817  $ (3,535) $ 17,592  $ (2,378) Adjustments Income tax provision --  (220) (15,305) (650) Litigation charges --  4,101  --  4,101  Non-GAAP net income $ 817  346  $ 2,287  $ 1,073  Basic net income (loss) per share $ .05  $ (.23) $ 1.09  $ (.16) Adjustments --  .25  (.95) .23  Non-GAAP basic net income per share $ .05  $ .02  $ .14  $ .07    Diluted net income (loss) per share $ .05  $(.23) $1.05  $(.16) Adjustments --  .25  (.91) .23  Non-GAAP diluted net income per share $ .05  $ .02  $ .14  $ .07  Shares used in computing basic net income per share 17,185  15,130  16,128  15,119  Shares used in computing diluted net income per share 17,807  15,715  16,794  15,710  CYBEX INTERNATIONAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (unaudited) September 30, 2006 December 31, 2005     ASSETS Current assets: Cash $ 2,327  $ 807  Accounts receivable, net 15,174  18,320  Inventories 9,791  9,258  Prepaid expenses and other 3,319  2,707  Deferred tax asset   4,140    --  Total current assets 34,751  31,092  Property and equipment, net 12,193  12,124  Goodwill 11,247  11,247  Deferred tax asset 9,699  --  Other assets   1,277    1,209  $ 69,167  $ 55,672    LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Current maturities of long-term debt $ --  $ 3,929  Current portion of capital leases 323  481  Accounts payable 6,109  5,918  Accrued expenses   17,468    16,286  Total current liabilities 23,900  26,614  Long-term debt --  9,730  Capital leases, excluding current portion 120  332  Other liabilities   1,960    2,808  Total liabilities 25,980  39,484  Stockholders’ equity   43,187    16,188  $ 69,167  $ 55,672  Cybex International, Inc. (AMEX: CYB), a leading exercise equipment manufacturer, today reported results for the third quarter ended September 30, 2006. Net sales for the third quarter 2006 were $29,849,000, compared to $26,690,000 for the third quarter 2005, an increase of 12%. On a GAAP basis, the Company reported net income for the third quarter of 2006 of $817,000, or $.05 per diluted share, compared to a net loss of $3,535,000, or $(.23) per diluted share, for the corresponding period of 2005. Excluding a third quarter 2005 litigation-related charge, and after an adjustment to the tax provision as described below, the Company's third quarter 2005 non-GAAP net income was $346,000, or $.02 per diluted share. For the nine months ended September 30, 2006, net sales were $88,712,000, compared to $78,646,000 for 2005, an increase of 13%. On a GAAP basis, the Company reported net income for the nine months ended September 30, 2006 of $17,592,000, or $1.05 per diluted share, compared to a net loss of $2,378,000, or $(.16) per diluted share, for the corresponding period of 2005. Excluding a second quarter 2006 reduction of the valuation reserve for deferred taxes and the third quarter 2005 litigation-related charge, and after adjustments to the Company's tax provision for each period as described below, the Company's non-GAAP net income for the nine months ended September 30, 2006 was $2,287,000, or $.14 per diluted share, compared to non-GAAP net income of $1,073,000, or $.07 per diluted share, for the corresponding 2005 period. Actual GAAP results for the nine months ended September 30, 2006, include a $14,421,000 reduction in the Company's deferred tax valuation reserve, resulting in a net tax benefit of $13,735,000 for the nine months ended September 30, 2006. Actual GAAP results for the third quarter and nine months ended September 24, 2005 included an increase in the Company's litigation reserve resulting in a pre-tax charge of $4,101,000. This increase in the litigation reserve reflected the jury verdict in a patent infringement case and the reversal on appeal of a summary judgment in favor of the Company in another patent infringement case. The Company's appeal of the jury verdict is pending and it continues to vigorously defend the other patent infringement suit which has since returned to the trial level. The Company's deferred tax valuation reserve was reduced effective July 1, 2006, and the GAAP results for the quarter and nine months ended September 30, 2006 include a third quarter 2006 tax provision reflecting an effective tax rate of approximately 41%. The 2006 non-GAAP results include a tax provision calculated as though the Company's effective tax rate for the third quarter 2006 was applicable for all of the first nine months of 2006, while the 2005 non-GAAP results include a tax provision at approximately the same effective rate. The non-GAAP adjustments have been made to provide a basis for reviewing the Company's operating performance on a consistent basis for all of the periods presented. John Aglialoro, Chairman and CEO, stated, "We are excited about our re-entry into the high-end consumer market with our recent introduction of our Consumer Arc Trainer. The Company is aggressively advancing our new product development pace and CYBEX is poised for an exciting new product line-up for 2007." Cybex International, Inc. is a leading manufacturer of premium exercise equipment for commercial and consumer use. The CYBEX product line includes a full range of both strength training and cardio training machines sold worldwide under the CYBEX brand. Products and programs are designed and engineered to reflect the natural movement of the human body, assisting each unique user - from the professional athlete to the first-time exerciser - to improve daily human performance. For more information on CYBEX and its product line, please visit the Company's website at www.cybexinternational.com. This news release may contain forward-looking statements. There are a number of risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made above. These include, but are not limited to, competitive factors, technological and product developments, market demand, economic conditions, the resolution of litigation involving the Company, and the ability of the Company to comply with the terms of its credit facilities. Further information on these and other factors which could affect the Company's financial results can be found in the Company's previously filed Report on Form 10-K, its Reports on Form 10-Q, its Current Reports on Form 8-K, and its proxy statement dated April 4, 2006. -0- *T CYBEX INTERNATIONAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - ACTUAL (In thousands, except per share data) (unaudited) Three Months Ended Nine Months Ended ------------------- ------------------- September September September September 30, 24, 30, 24, 2006 2005 2006 2005 --------- --------- --------- --------- Net sales $29,849 $26,690 $ 88,712 $78,646 Cost of sales 19,269 17,143 56,719 50,593 --------- --------- --------- --------- Gross profit 10,580 9,547 31,993 28,053 As a percentage of sales 35.4% 35.8% 36.1% 35.7% Selling, general and administrative expenses 9,052 8,276 26,973 24,325 Litigation charges -- 4,101 -- 4,101 --------- --------- --------- --------- Operating income (loss) 1,528 (2,830) 5,020 (373) Interest expense, net 150 679 1,163 1,894 --------- --------- --------- --------- Income (loss) before income taxes 1,378 (3,509) 3,857 (2,267) Income tax provision (benefit) 561 26 (13,735) 111 --------- --------- --------- --------- Net income (loss) $ 817 $(3,535) $ 17,592 $(2,378) ========= ========= ========= ========= Basic net income (loss) per share $ .05 $ (.23) $ 1.09 $ (.16) ========= ========= ========= ========= Diluted net income (loss) per share $ .05 $ (.23) $ 1.05 $ (.16) ========= ========= ========= ========= Shares used in computing basic net income (loss) per share 17,185 15,130 16,128 15,119 ========= ========= ========= ========= Shares used in computing diluted net income (loss) per share 17,807 15,130 16,794 15,119 ========= ========= ========= ========= *T -0- *T CYBEX INTERNATIONAL, INC. RECONCILIATION OF GAAP TO NON-GAAP RESULTS (In thousands, except per share data) (unaudited) Three Months Ended Nine Months Ended ------------------------ ----------------------- September 30, September September 30, September 2006 24, 2005 2006 24, 2005 -------------- --------- ------------- --------- GAAP net income (loss) $817 $(3,535) $17,592 $(2,378) Adjustments Income tax provision -- (220) (15,305) (650) Litigation charges -- 4,101 -- 4,101 -------------- --------- ------------- --------- Non-GAAP net income $817 346 $2,287 $1,073 ============== ========= ============= ========= Basic net income (loss) per share $.05 $(.23) $1.09 $(.16) Adjustments -- .25 (.95) .23 -------------- --------- ------------- --------- Non-GAAP basic net income per share $.05 $.02 $.14 $.07 ============== ========= ============= ========= Diluted net income (loss) per share $.05 $(.23) $1.05 $(.16) Adjustments -- .25 (.91) .23 -------------- --------- ------------- --------- Non-GAAP diluted net income per share $.05 $.02 $.14 $.07 ============== ========= ============= ========= Shares used in computing basic net income per share 17,185 15,130 16,128 15,119 ============== ========= ============= ========= Shares used in computing diluted net income per share 17,807 15,715 16,794 15,710 ============== ========= ============= ========= *T -0- *T CYBEX INTERNATIONAL, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (unaudited) September 30, December 31, 2006 2005 -------------- --------------- ASSETS Current assets: Cash $ 2,327 $ 807 Accounts receivable, net 15,174 18,320 Inventories 9,791 9,258 Prepaid expenses and other 3,319 2,707 Deferred tax asset 4,140 -- -------------- --------------- Total current assets 34,751 31,092 Property and equipment, net 12,193 12,124 Goodwill 11,247 11,247 Deferred tax asset 9,699 -- Other assets 1,277 1,209 -------------- --------------- $69,167 $55,672 ============== =============== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current maturities of long-term debt $ -- $ 3,929 Current portion of capital leases 323 481 Accounts payable 6,109 5,918 Accrued expenses 17,468 16,286 -------------- --------------- Total current liabilities 23,900 26,614 Long-term debt -- 9,730 Capital leases, excluding current portion 120 332 Other liabilities 1,960 2,808 -------------- --------------- Total liabilities 25,980 39,484 Stockholders' equity 43,187 16,188 -------------- --------------- $69,167 $55,672 ============== =============== *T

1 Year WisdomTree Chinese Yuan ... Chart

1 Year WisdomTree Chinese Yuan ... Chart

1 Month WisdomTree Chinese Yuan ... Chart

1 Month WisdomTree Chinese Yuan ... Chart

Your Recent History

Delayed Upgrade Clock